Clinical outcomes of levosimendan administration in veno-arterial extracorporeal membrane oxygenation: a meta-analysis
BMJ Open · 2025-09 · 15 (9) · e101995
DOI: 10.1136/bmjopen-2025-101995 ↗Kurz gefasst
Metaanalyse in der Zeitschrift BMJ Open, online erschienen am 30.09.2025. Verfasst von Guo-Min Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Simendan, Extracorporeal Membrane Oxygenation, Shock, Cardiogenic, Cardiotonic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: 2022 Beijing Major Epidemic Prevention and Control Key Speciality Intensive Care Medical Construction Project.
Abstract (Originalsprache)
Objectives
To evaluate the effectiveness of levosimendan in promoting weaning from veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in patients with refractory cardiogenic shock through a meta-analysis of clinical trials.
Design
Systematic review and meta-analysis. Data sources PubMed, Embase, the Cochrane Library and Web of Science were systematically searched from inception to January 2025. Eligibility criteria Studies were included if they were clinical trials comparing outcomes between patients receiving levosimendan and those not receiving it during VA-ECMO support. Eligible studies reported on at least one of the predefined outcomes. Data extraction and synthesis Two independent reviewers extracted data and assessed study quality. The primary outcome was successful VA-ECMO weaning. Secondary outcomes included 30-day mortality, in-hospital mortality, duration of ECMO support and length of stay in the intensive care unit (ICU). A random-effects model was used to synthesise data and estimate pooled effect sizes, with heterogeneity assessed using the I² statistic.
Results
Involving 2083 patients across 16 studies, levosimendan significantly improved VA-ECMO weaning success (OR=2.44, 95% CI: 1.72 to 3.48; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
- Emergency and Critical Care Medical Centre, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
- Clinical and Research Centre on Acute Lung Injury, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
- Department of Geriatric Medicine, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
- Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, Beijing, China arnold_lhl@126.com zhoujx.cn@icloud.com.
Förderung
- 2022 Beijing Major Epidemic Prevention and Control Key Speciality Intensive Care Medical Construction Project
Zitieren
APA
Zhao, G. M., Zhao, G. M., Zhang, H., Chen, W., Zhou, J. X., & Li, H. L. (2025). Clinical outcomes of levosimendan administration in veno-arterial extracorporeal membrane oxygenation: a meta-analysis. BMJ Open, 15(9), e101995. https://doi.org/10.1136/bmjopen-2025-101995
Vancouver
Zhao GM, Zhao GM, Zhang H, Chen W, Zhou JX, Li HL. Clinical outcomes of levosimendan administration in veno-arterial extracorporeal membrane oxygenation: a meta-analysis. BMJ Open. 2025;15(9):e101995. doi:10.1136/bmjopen-2025-101995
BibTeX
@article{Zhao2025,
author = {Zhao, Guo-Min and Zhao, Guo-Mei and Zhang, Hui and Chen, Wei and Zhou, Jian-Xin and Li, Hong-Liang},
title = {Clinical outcomes of levosimendan administration in veno-arterial extracorporeal membrane oxygenation: a meta-analysis},
journal = {BMJ Open},
year = {2025},
volume = {15},
number = {9},
pages = {e101995},
doi = {10.1136/bmjopen-2025-101995}
}
EUVIMED